This Slide: #36 of 100 |
Slide #36. Forest Laboratories, Inc. — Aptalis
Acquirer:
Forest Laboratories, Inc. (FRX)
Acquiree:
Aptalis
Details:
Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company, today announced the completion of its acquisition of Aptalis, a privately held specialty pharmaceutical company focused on gastrointestinal disorders and cystic fibrosis. The companies will begin combined operations today, with Aptalis operating as a subsidiary of Forest Laboratories, Inc.
Forest Road is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Open the FRX Page at The Online Investor »
|
Open the FRX Page at The Online Investor (in a new window) »
Free FRX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.47 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |